跳至主要内容
临床试验/NCT04924855
NCT04924855Unknown不适用

Estimation of Dynamics of Humoral Immunity in COVID-19 Vaccined Health Care Workers

General Administration of Military Health, Tunisia1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2021年7月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
300
试验地点
1
主要终点
Vaccine effectiveness

研究概览

简要总结

The purpose of the research is to evaluate kinetic after vaccination to the COVID-19 coronavirus by measurements of specific and neutralizant antibodies for spike antigenic sequences .

This work will allow us to follow the efficacy and tolerance of the vaccine over a year, to evaluate the antibody profile, their kinetics, the fraction of neutralising antibodies and will also allow us to understand the attitudes to be taken to ensure the best protection for our staff

详细描述

Our objective is to follow the hospital staff after vaccination, for this we will include two groups of participants:

G1: vaccinated staff who did not contract the virus (at the date of vaccination) and who had a serology <0 at least at D7 of the date of vaccination dose 1 (known serological value) G2: vaccinated personnel who have contracted the virus with a PCR + and who have positive serology at least at D7 of the date of vaccination (known serological value)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RB-approved informed consent, age 18 years or older, male or female, anyone considering COVID-19 vaccination or anyone that has received COVID-19 vaccination.
  • Subjects can enroll at anytime after vaccination even though they may not have enrolled before vaccination.
  • Sampling Frequency and timing: Up to 8 total samples in 12 months -

排除标准

  • Exclusion: Failure to provide informed consent

结局指标

主要结局

Vaccine effectiveness

时间窗: 1 year

antibody kinetics

次要结局

  • the tolerance of the vaccine(1 year)

研究者

发起方
General Administration of Military Health, Tunisia
申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验